The trial enrolled 281 participants across 42 research and healthcare centers in the United States, randomized to once-weekly subcutaneous retatrutide (0.5, 4, 8, or 12 mg), once-weekly subcutaneous dulaglutide 1.5 mg (active comparator), or placebo, over a 36-week treatment period
By any measure, the majority of the entire BPC-157 literature comes from this one group
Some peptides, known as growth hormone secretagogues (GHS), facilitate muscle development and recuperation
Derived from amino acids, L-carnitine is normally concentrated in the testis and epididymis
Dutasteride: a review of current data on a novel dual inhibitor of 5-alpha reductase.Rev Urol2005;7:203-210 89